{"log_id": 948001987783678396, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 6.9e-05, "average": 0.994636, "min": 0.962312}, "location": {"width": 731, "top": 204, "height": 64, "left": 201}, "words": "普芦卡必利是一种二氢苯并呋喃甲酰胺类化合物,为选择性、高亲和力的五羟色胺"}, {"probability": {"variance": 0.000747, "average": 0.98734, "min": 0.847483}, "location": {"width": 777, "top": 250, "height": 66, "left": 179}, "words": "5-HT)受体激动剂,具有促肠动力活性。体内外研究结果显示,普芦卡必利可通过5HT"}, {"probability": {"variance": 7.1e-05, "average": 0.99523, "min": 0.963559}, "location": {"width": 494, "top": 311, "height": 52, "left": 164}, "words": "受体激活作用来增强胃肠道中蠕动反射和推进运动模式"}, {"probability": {"variance": 3e-06, "average": 0.996655, "min": 0.993961}, "location": {"width": 85, "top": 379, "height": 26, "left": 178}, "words": "毒理研究"}, {"probability": {"variance": 2e-06, "average": 0.998934, "min": 0.996199}, "location": {"width": 105, "top": 421, "height": 28, "left": 216}, "words": "安全药理学"}, {"probability": {"variance": 6e-05, "average": 0.995765, "min": 0.955178}, "location": {"width": 762, "top": 436, "height": 64, "left": 210}, "words": "麻醉猪静脉给药后可见心率和血压轻微升高,清醒犬静脉给药后可见血压升高,但麻醉"}, {"probability": {"variance": 0.000191, "average": 0.992192, "min": 0.932562}, "location": {"width": 512, "top": 495, "height": 54, "left": 170}, "words": "犬或清醒犬经口给药达到相似血药浓度时均未见类似现象"}, {"probability": {"variance": 0.003973, "average": 0.974849, "min": 0.660898}, "location": {"width": 759, "top": 528, "height": 67, "left": 213}, "words": "普芦卡必利浓度高达1μM(相当于人体治疗剂量时血药浓度7.5ng/mL的49倍)时未"}, {"probability": {"variance": 0.014833, "average": 0.937243, "min": 0.536371}, "location": {"width": 803, "top": 575, "height": 66, "left": 175}, "words": "影响hERG转染HEK293或COS-7细胞中的Ik电流,对I电流抑制作用的ECSs0值为41-22"}, {"probability": {"variance": 0.00381, "average": 0.97891, "min": 0.623237}, "location": {"width": 802, "top": 620, "height": 68, "left": 177}, "words": "μM(200—1100倍人体治疗血药浓度)。兔和犬浦肯野纤维、兔心脏和豚鼠乳头肌等组织的"}, {"probability": {"variance": 0.000317, "average": 0.994572, "min": 0.885161}, "location": {"width": 803, "top": 668, "height": 64, "left": 177}, "words": "离体试验中,普芦卡必利浓度高达1μM时对动作电位时程未见影响。静脉注射普芦卡必利"}, {"probability": {"variance": 0.000322, "average": 0.994229, "min": 0.888764}, "location": {"width": 804, "top": 713, "height": 65, "left": 179}, "words": "可引起清醒犬和麻醉猪收缩压和舒张压升高,但在普芦卡必利浓度相当于人体治疗血药浓度"}, {"probability": {"variance": 7e-06, "average": 0.99783, "min": 0.990125}, "location": {"width": 270, "top": 784, "height": 40, "left": 179}, "words": "时未见其它相关的心血管作用"}, {"probability": {"variance": 1.5e-05, "average": 0.997277, "min": 0.990567}, "location": {"width": 87, "top": 840, "height": 29, "left": 183}, "words": "遗传毒性"}, {"probability": {"variance": 0.002083, "average": 0.98663, "min": 0.719385}, "location": {"width": 762, "top": 850, "height": 65, "left": 226}, "words": "普芦卡必利Ames试验结果阳性、体外大鼠肝细胞程序外DNA合成试验(UDS)结果"}, {"probability": {"variance": 0.003712, "average": 0.982611, "min": 0.611882}, "location": {"width": 806, "top": 897, "height": 65, "left": 186}, "words": "阳性,小鼠淋巴瘤细胞试验、人外周血淋巴细胞染色体畸变试验、小鼠微核试验、体内UDS"}, {"probability": {"variance": 0.000101, "average": 0.996418, "min": 0.955411}, "location": {"width": 412, "top": 959, "height": 49, "left": 190}, "words": "试验和体内转基因 Big Blue试验结果均为阴性"}, {"probability": {"variance": 0, "average": 0.999027, "min": 0.998528}, "location": {"width": 86, "top": 1025, "height": 26, "left": 191}, "words": "生殖毒性"}, {"probability": {"variance": 6.1e-05, "average": 0.994448, "min": 0.96222}, "location": {"width": 757, "top": 1033, "height": 66, "left": 233}, "words": "大鼠经口给予普芦卡必利剂量高达20mg/kg时,生育力与早期胚胎毒性试验及围产期"}, {"probability": {"variance": 0.000522, "average": 0.991563, "min": 0.879972}, "location": {"width": 799, "top": 1080, "height": 65, "left": 194}, "words": "毒性试验中未见明显不良反应。生育力与早期胚胎毒性试验中80mg/kg可延长交配前间隔"}, {"probability": {"variance": 0.000185, "average": 0.99216, "min": 0.926353}, "location": {"width": 798, "top": 1125, "height": 67, "left": 196}, "words": "和增加着床前丢失,可能与催乳素介导的作用相关;围产期毒性试验中80mg/kg可见妊娠"}, {"probability": {"variance": 6.4e-05, "average": 0.994527, "min": 0.960349}, "location": {"width": 790, "top": 1171, "height": 65, "left": 198}, "words": "子宫重量轻微降低和黄体数量的少量减少。胚胎胎仔发育毒性试验中,大鼠和兔经口给予"}, {"probability": {"variance": 0.009985, "average": 0.964454, "min": 0.484314}, "location": {"width": 782, "top": 1216, "height": 69, "left": 199}, "words": "80mg/kg,未见致畸作用或其它胚胎毒性,大鼠的暴露量(基于Cmax)相当于人体的938倍"}, {"probability": {"variance": 8.2e-05, "average": 0.993718, "min": 0.973667}, "location": {"width": 319, "top": 1278, "height": 41, "left": 380}, "words": "为38倍。在大鼠和犬中进行了给药"}, {"probability": {"variance": 0.009283, "average": 0.963302, "min": 0.627615}, "location": {"width": 288, "top": 1265, "height": 35, "left": 713}, "words": "周和一个月的新生动物/幼年动物"}, {"probability": {"variance": 2.3e-05, "average": 0.993427, "min": 0.984852}, "location": {"width": 130, "top": 1298, "height": 29, "left": 202}, "words": "兔(基于AUC"}, {"probability": {"variance": 0.008544, "average": 0.953676, "min": 0.597766}, "location": {"width": 804, "top": 1303, "height": 77, "left": 202}, "words": "毒性试验,犬的无毒性反应剂量( NOAEL)为5mgkg;但各剂量(5~80m可"}, {"probability": {"variance": 0.014664, "average": 0.720665, "min": 0.493166}, "location": {"width": 106, "top": 1359, "height": 27, "left": 888}, "words": "HARM不"}, {"probability": {"variance": 5.3e-05, "average": 0.99676, "min": 0.971021}, "location": {"width": 288, "top": 1379, "height": 41, "left": 206}, "words": "见包括体重增量下降在内的影响"}, {"probability": {"variance": 0.022768, "average": 0.922815, "min": 0.453991}, "location": {"width": 833, "top": 1410, "height": 110, "left": 248}, "words": "小鼠与大鼠普芦卡必利两年致癌性试验中,小鼠剂量高达80mg大剂"}, {"probability": {"variance": 0, "average": 0.999799, "min": 0.999506}, "location": {"width": 65, "top": 1438, "height": 26, "left": 208}, "words": "致癌性"}, {"probability": {"variance": 0.01551, "average": 0.928819, "min": 0.385608}, "location": {"width": 847, "top": 1482, "height": 80, "left": 212}, "words": "40(雌性)和80(雄性)mgkg天。小鼠在剂量为80mgkg天(以AUC计,露量大"}, {"probability": {"variance": 0.000748, "average": 0.986876, "min": 0.851823}, "location": {"width": 801, "top": 1537, "height": 65, "left": 212}, "words": "最大临床推荐日剂量时暴露量(MRHD)的200倍),可见乳腺腺癌发生率增加:无影响剂量"}, {"probability": {"variance": 0.006581, "average": 0.947971, "min": 0.807527}, "location": {"width": 114, "top": 1640, "height": 40, "left": 1083}, "words": "仅供存档"}], "language": 3}